CymaBay Therapeutics CBAY
$ 32.48
0.0%
Annual report 2023
added 02-28-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Sujal Shah |
Employees in the company |
36 |
Shares |
106 M |
Market Cap[1] |
$ 3.45 B |
EBITDA (LTM) |
$ -95.3 M |
P/E (LTM) |
-18.33 |
P/S (LTM) |
- |
EPS (LTM) |
-0.9 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.